Posted by Michael Wonder on 28 Nov 2019
Advancing legislation on drug pricing — is there a path forward?
28 November 2019 - The Lower Drug Costs Now Act of 2019 represents a major departure from the U.S. status quo.
It has several key but politically divisive provisions targeting prices paid to drug manufacturers and would reduce Medicare spending and beneficiaries’ out-of-pocket costs.
